Company intelligence / Profile preview
TherapyX Inc.
Buffalo, New York, United Statestherapyxinc.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has developed multiple preclinical candidates using their proprietary EXStaM platform. Their lead products have demonstrated efficacy in animal models of disease and are being prepared for clinical trials.
- Therapeutic areas
- GastroenterologyOncologyImmunologyInfectious Diseases
- Modalities
- Sustained-release microparticulate protein therapeuticsbiologicstherapeutic vaccinesprophylactic vaccinessmall molecule drugsinterleukins
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
IntravaccUniversity of Rochester
Beyond the preview
Go deeper on TherapyX Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TherapyX Inc..